Med Ed Report briefs: May 2014

Kathleen Sebelius
Kathleen Sebelius

Before resigning, former HHS Secretary Kathleen Sebelius fielded one last question about the Sunshine Act from Sen. Chuck Grassley, one of the act's co-authors, who asked her to assure providers that they “can have confidence that the data made publicly available…will have explicit context.” Sebelius said she could not answer that specifically, but would check on the answer and get back to him, according to a transcript of their exchange on the blog

Murray Kopelow, MD, president and chief executive of the ACCME, said he will retire next year. At the time of his retirement—July 31, 2015—he will have completed 30 years of service in CME, including 20 years as chief executive of ACCME.

Haymarket Medical Education's application to become an accredited provider of CME was approved last month. HME, owned by the same parent company as MM&M, operates independently.

Medical-tech firm Smith & Nephew provided a restricted educational grant to the Wound, Ostomy and Continence Nurses Society (WOCN) to support Wound, Ostomy and Continence (WOC) Nurse Week (April 13-19).

You must be a registered member of MMM to post a comment.

Email Newsletters

What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.

A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.